Lenalidomide and Prednisone in Treating Patients With Myelofibrosis

NCT00227591 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

NIH

Sponsor class

Conditions

Essential Thrombocythemia
Polycythemia Vera
Primary Myelofibrosis

Interventions

DRUG: lenalidomide
DRUG: prednisone
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)